|
Dispelling Some Of The COVID-19 Unknowns
Issues & Insights | Henry Miller, M.S., M.D.
April 2, 2020
On the medical front, let’s consider what we do know. First and foremost, the situation in the U.S. continues to worsen. The nation’s death toll is rising exponentially, and the steepness of New York’s curve is terrifying. So are the number of confirmed infections, but that statistic is of limited value, inasmuch as its accuracy depends on the (now finally increasing) numbers of tests conducted.
|
|
Listen to PRI's "Next Round" Podcast
Mark Skousen – On These Uncertain Times
March 30, 2020
Dr. Mark Skousen is one of the most prominent libertarians in the country and founder of FreedomFest – the largest gathering of libertarians in the world. Dr. Skousen also teaches economics at Chapman University. In this podcast, we discuss the economic impact of the coronavirus, the financial markets, politics, California, and teaching economics to a new generation.
Click here to listen . . .
In coronavirus battle, price controls would make it harder to develop lifesaving drugs
Fox News | Sally C. Pipes
March 30, 2020
Investors only fund these risky projects if they foresee a reasonable chance of recouping their money. That’s why so much drug research occurs in the United States, which has fewer rules governing drug prices than other developed nations. U.S. companies develop half of all new medicines; European firms are responsible for just a third.
| | | | |
